Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: Preliminary results from the TREAT Asia HIV Observational Database (TAHOD)

HIV Medicine

Volumn 6, Issue 3, 2005, Pages 216-223

  Zhou, Julian ^a,c   Kumarasamy, N ^b   Zhang, F ^d   Zhao, H ^d   Han, N ^d   Li, P ^e   Lee, M P ^e   Chen, Y M A ^f   Wong, W W ^f   Wang, D C C ^f   Anand, S ^b   Cecelia, J A ^b   Pujari, S ^g   Joshi, K ^g   Lee, C K C ^h   Kaur, S ^h,i   Kamarulzaman, A ⁱ   Ditangco, R ^j   Capistrano, R ^j   Paton, N I ^k   Yap, M ^k   Phanuphak, P ^l   Siangphe, U ^l   Khongphattanayothing, M ^l   Vibhagool, A ^m   Kiertiburanakul, S ^m   Kiatatchasai, W ^m   Chuah, J ⁿ   Fankhauser, W ⁿ   Dickson, B ⁿ   Frost, K ^o   Wong, S ^o   Cooper, D A ^a   Law, M G ^a   Petoumenos, K ^a   more..

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^c Beijing Ditan Hospital ^*  (Australia)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g HIV Project   (India)

^h HOSPITAL KUALA LUMPUR   (Malaysia)

ⁱ UNIVERSITY OF MALAYA   (Malaysia)

^j RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^k TAN TOCK SENG HOSPITAL   (Singapore)

^l THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^m MAHIDOL UNIVERSITY   (Thailand)

ⁿ Gold Coast Sexual Health Clinic   (Australia)

^o Amer Foundation for AIDS Research   (United States)

more..

Author keywords

AIDS; Disease progression; HIV; Observational Database

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HEMOGLOBIN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ASIA; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DEATH; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NONBIOLOGICAL MODEL; OUTCOMES RESEARCH; PACIFIC ISLANDS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SYMPTOM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ALGORITHMS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIA; CD4 LYMPHOCYTE COUNT; DATABASES, FACTUAL; DEVELOPING COUNTRIES; DISEASE PROGRESSION; FEMALE; HEMOGLOBINS; HIV INFECTIONS; HIV-1; HUMANS; MALE; PACIFIC ISLANDS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; VIRAL LOAD;

EID: 21144454512     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2005.00292.x     Document Type: Article

References (20)

1. Egger M, Hirschel B, Francioli P et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. Br Med J 1997; 315: 1194-1199.
2. Egger M, May M, Chene G et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360: 119-129.
3. Hogg RS, Heath KV, Yip B et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. J Am Med Assoc 1998; 279: 450-454.
4. Mocroft A, Vella S, Benfield TL et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Eurosida Study Group. Lancet 1998; 352: 1725-1730.
5. Mocroft A, Phillips AN, Friis-Moller N et al. Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study. Antivir Ther 2002; 7: 21-30.
6. Miller V, Phillips AN, Clotet B et al. Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts. J Infect Dis 2002; 186: 189-197.
7. Lundgren JD, Mocroft A, Gatell JM et al. A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study. J Infect Dis 2002; 185: 178-187.
8. Mocroft A, Ledergerber B, Katlama C et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362: 22-29.
9. Zhou J, Kumarasamy N, Ditangco R et al. The TREAT Asia HIV Observational Database: Baseline and Retrospective Data. J Acquir Immune Defic Syndr 2005; 38: 174-179.
10. Mocroft A, Kirk O, Barton SE et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. Eurosida Study Group. AIDS 1999; 13: 943-950.
11. Lundgren JD, Mocroft A. Anemia and survival in human immunodeficiency virus. Clin Infect Dis 2003; 37 (Suppl. 4): S297-S303.
12. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality weekly Report (MMWR) 1992; 41: 1-19.
13. Palella FJ Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-860.
14. Wannamethee SG, Sirivichayakul S, Phillips AN et al. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok. Thailand Int J Epidemiol 1998; 27: 289-295.
15. Coakley EP, Samore MH, Gillis JM et al. The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of less than or equal to 50 × 10(6) cells/l. AIDS 2000; 14: 1147-1153.
16. Sterling TR, Chaisson RE, Moore RD. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy. AIDS 2001; 15: 2251-2257.
17. Kumarasamy N, Solomon S, Flanigan TP et al. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis 2003; 36: 79-85.
18. World Health Organisation (WHO). Scaling up Antiretroviral Therapy in Resource-Limited Settings. Guidelines for a Public Health Approach. 2003 Revision. Geneva, World Health Organisation, 2004.
19. Kumarasamy N, Flanigan TP, Mahajan AP et al. Monitoring HIV treatment in the developing world. Lancet Infect Dis 2002; 2: 656-657.
20. Stephenson J. Cheaper HIV drugs for poor nations bring a new challenge: monitoring treatment. J Am Med Assoc 2002; 288: 151-153.